Bullock N - Search Results

1

Cyclophosphamide resistance in medulloblastoma.

Friedman HS, Colvin OM, Kaufmann SH, Ludeman SM, Bullock N, Bigner DD, Griffith OW. Friedman HS, et al. Among authors: bullock n. Cancer Res. 1992 Oct 1;52(19):5373-8. Cancer Res. 1992. PMID: 1356617

2

The gene expression profiles of medulloblastoma cell lines resistant to preactivated cyclophosphamide.

Bacolod MD, Lin SM, Johnson SP, Bullock NS, Colvin M, Bigner DD, Friedman HS. Bacolod MD, et al. Among authors: bullock ns. Curr Cancer Drug Targets. 2008 May;8(3):172-9. doi: 10.2174/156800908784293631. Curr Cancer Drug Targets. 2008. PMID: 18473730 Free PMC article.

3

Mechanisms of resistance to 1,3-bis(2-chloroethyl)-1-nitrosourea in human medulloblastoma and rhabdomyosarcoma.

Bacolod MD, Johnson SP, Ali-Osman F, Modrich P, Bullock NS, Colvin OM, Bigner DD, Friedman HS. Bacolod MD, et al. Mol Cancer Ther. 2002 Jul;1(9):727-36. Mol Cancer Ther. 2002. PMID: 12479369

4

Brain tumor cell lines resistant to O6-benzylguanine/1,3-bis(2-chloroethyl)-1-nitrosourea chemotherapy have O6-alkylguanine-DNA alkyltransferase mutations.

Bacolod MD, Johnson SP, Pegg AE, Dolan ME, Moschel RC, Bullock NS, Fang Q, Colvin OM, Modrich P, Bigner DD, Friedman HS. Bacolod MD, et al. Mol Cancer Ther. 2004 Sep;3(9):1127-35. Mol Cancer Ther. 2004. PMID: 15367707

5

BCNU-sequestration by metallothioneins may contribute to resistance in a medulloblastoma cell line.

Bacolod MD, Fehdrau R, Johnson SP, Bullock NS, Bigner DD, Colvin M, Friedman HS. Bacolod MD, et al. Cancer Chemother Pharmacol. 2009 Mar;63(4):753-8. doi: 10.1007/s00280-008-0792-9. Epub 2008 Jul 17. Cancer Chemother Pharmacol. 2009. PMID: 18633619 Free PMC article.

6

Effects of glutathione or polyamine depletion on in vivo thermosensitization.

Laskowitz DT, Elion GB, Dewhirst MW, Griffith OW, Casero RA Jr, Scott PA, Bullock N, Bigner DD, Friedman HS. Laskowitz DT, et al. Among authors: bullock n. Int J Hyperthermia. 1992 Mar-Apr;8(2):199-208. doi: 10.3109/02656739209021775. Int J Hyperthermia. 1992. PMID: 1573309 Free article.

7

Repair analysis of 4-hydroperoxycyclophosphamide-induced DNA interstrand crosslinking in the c-myc gene in 4-hydroperoxycyclophosphamide-sensitive and -resistant medulloblastoma cell lines.

Dong Q, Bullock N, Ali-Osman F, Colvin OM, Bigner DD, Friedman HS. Dong Q, et al. Among authors: bullock n. Cancer Chemother Pharmacol. 1996;37(3):242-46. doi: 10.1007/BF00688323. Cancer Chemother Pharmacol. 1996. PMID: 8529284

8

Analysis of DNA mismatch repair proteins in human medulloblastoma.

Lee SE, Johnson SP, Hale LP, Li J, Bullock N, Fuchs H, Friedman A, McLendon R, Bigner DD, Modrich P, Friedman HS. Lee SE, et al. Among authors: bullock n. Clin Cancer Res. 1998 Jun;4(6):1415-9. Clin Cancer Res. 1998. PMID: 9626457

9

Multiple DNA repair mechanisms and alkylator resistance in the human medulloblastoma cell line D-283 Med (4-HCR).

Dong Q, Johnson SP, Colvin OM, Bullock N, Kilborn C, Runyon G, Sullivan DM, Easton J, Bigner DD, Nahta R, Marks J, Modrich P, Friedman HS. Dong Q, et al. Among authors: bullock n. Cancer Chemother Pharmacol. 1999;43(1):73-9. doi: 10.1007/s002800050865. Cancer Chemother Pharmacol. 1999. PMID: 9923544

10

Modulation of cyclophosphamide activity by O6-alkylguanine-DNA alkyltransferase.

Friedman HS, Pegg AE, Johnson SP, Loktionova NA, Dolan ME, Modrich P, Moschel RC, Struck R, Brent TP, Ludeman S, Bullock N, Kilborn C, Keir S, Dong Q, Bigner DD, Colvin OM. Friedman HS, et al. Among authors: bullock n. Cancer Chemother Pharmacol. 1999;43(1):80-5. doi: 10.1007/s002800050866. Cancer Chemother Pharmacol. 1999. PMID: 9923545

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

97 results

Search Page